- Home
- JKHY vs RVTY Comparison
JKHY vs RVTY Comparison
Compare JKHY & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JKHY | RVTY |
|---|---|---|
| Founded | 1976 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 11.6B |
| IPO Year | 2000 | 1994 |
Fundamental Metrics
Financial Performance| Metric | JKHY | RVTY |
|---|---|---|
| Price | $153.68 | $113.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 16 |
| Target Price | ★ $197.25 | $109.67 |
| AVG Volume (30 Days) | 1.1M | ★ 1.3M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.59% | 0.34% |
| EPS Growth | ★ 19.31 | N/A |
| EPS | ★ 5.41 | 0.36 |
| Revenue | $1,536,603,000.00 | ★ $3,311,822,000.00 |
| Revenue This Year | $8.03 | $6.37 |
| Revenue Next Year | $6.39 | $5.10 |
| P/E Ratio | ★ $28.47 | $312.56 |
| Revenue Growth | ★ 7.37 | N/A |
| 52 Week Low | $121.04 | $81.22 |
| 52 Week High | $193.39 | $118.30 |
Technical Indicators
Market Signals| Indicator | JKHY | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 57.15 | 55.43 |
| Support Level | $146.28 | $95.31 |
| Resistance Level | $157.87 | $116.82 |
| Average True Range (ATR) | 4.52 | 3.66 |
| MACD | 0.13 | -0.20 |
| Stochastic Oscillator | 48.06 | 72.61 |
Price Performance
Historical ComparisonAbout JKHY Jack Henry & Associates Inc.
Jack Henry is a leading provider of core processing and complementary services, including electronic funds transfer, payment processing, and loan processing, for US banks and credit unions, with a focus on small and midsize banks. Jack Henry serves almost 1,000 banks and over 700 credit unions.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.